Pfizer Says Three Contaminated Drugs Are Not Sold In Chinese Market
This article was originally published in PharmAsia News
After Pfizer U.S. announced an emergency recall of two antibiotics (metronidazole and ciprofloxacin injection) and the antiemetic ondansetron, Pfizer China recently clarified that these three drugs are not sold in the Chinese market
You may also be interested in...
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.
The two companies announced more details about their COVID-19 vaccine development plan, including a $185m upfront payment and $113m equity investment from Pfizer.